ArticleNeuro-oncology2022

Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.

Chelsea Kotch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.